AnGes (AMGXF) YoY EBITDA Growth : 137.11% (As of Dec. 2024)

View and export this data going back to 2014. Start your Free Trial

What is AnGes YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. AnGes's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 137.11%.

AnGes's EBITDA per Share for the three months ended in Dec. 2024 was $0.04.

AnGes YoY EBITDA Growth Historical Data

The historical data trend for AnGes's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AnGes YoY EBITDA Growth Chart

AnGes Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-18.18

-133.14

19.16

48.98

51.08

AnGes Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															39.38	33.06	36.36	-	137.11

AnGes YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

AnGes's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(-0.159	-	-0.325)	/	\| -0.325 \|
=	51.08 %

AnGes's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(0.036	-	-0.097)	/	\| -0.097 \|
=	137.11 %

AnGes YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of AnGes's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

AnGes Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AnGes Inc (OTCPK:AMGXF) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

4563:Japan AJW:Germany

Address

7-7-15, Saito-asagi, 4F, Saito Bio-Incubator, Ibaraki, Osaka, JPN, 567-0085

Website

http://www.anges.co.jp

AnGes Inc is a biopharmaceutical company. The company's development projects include - HGF plasmid, NFkB decoy oligonucleotide, and Therapeutic vaccine.

AnGes Headlines

No Headlines